|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/53 | (2006.01) |
| A61K 31/47 | (2013.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/53 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3581183 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18751614.1 |
| Europos patento paraiškos padavimo data | 2018-02-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2018/004007 |
| Data | 2018-02-06 |
| (87) | Numeris | WO 2018/147275 |
| Data | 2018-08-16 |
| (30) | Numeris | Data | Šalis |
| 2017021542 | 2017-02-08 | JP |
| (72) |
OZAWA, Yoichi , JP
HORI, Yusaku , JP
YAMADA, Kazuhiko , JP
KAMIYAMA, Hiroshi , JP
MATSUKI, Masahiro , JP
|
| (73) |
Eisai R&D Management Co., Ltd. ,
4-6-10 Koishikawa
Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | TUMOR-TREATING PHARMACEUTICAL COMPOSITION |
| TUMOR-TREATING PHARMACEUTICAL COMPOSITION |